tetanus peptide melanoma vaccine

BIOLOGICAL2 trials

Sponsors

University of Virginia, Eastern Cooperative Oncology Group

Conditions

Melanoma (Skin)

Phase 2

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

CompletedNCT00071981

Eastern Cooperative Oncology GroupMelanoma (Skin)

Start: 2005-05-09End: 2014-01-31Updated: 2023-06-28

Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

CompletedNCT00003222

University of VirginiaMelanoma (Skin)

Start: 1998-04-30Updated: 2014-12-19